Showing results (21-30 of 6,269) with videos related to

Sort By:
Pageof 627
Diabetes, Obesity & Metabolism|June 6, 2022
Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease: A systematic review and network meta-analysisHongwei Cao, Tao Liu, Li Wang, et al.
Diabetes, Obesity & Metabolism|June 7, 2022
Hypoglycaemia and rebound hyperglycaemia increase left ventricular systolic function in patients with type 1 diabetesChristine R Andreasen, Andreas Andersen, Per G Hagelqvist, et al.
Diabetes, Obesity & Metabolism|June 9, 2022
Prognostic value of 24-hour ambulatory blood pressure patterns in diabetes: A 21-year longitudinal studyMartina Chiriacò, Luca Sacchetta, Giovanna Forotti, et al.
Diabetes, Obesity & Metabolism|June 9, 2022
Obesity-associated metabolites in relation to type 2 diabetes risk: A prospective nested case-control study of the CARRS cohortMohammed K Ali, M Masood Kadir, Unjali P Gujral, et al.
Diabetes, Obesity & Metabolism|July 8, 2022
The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosisJulia Moellmann, Pascal A Mann, Ben A Kappel, et al.
Diabetes, Obesity & Metabolism|November 26, 2022
A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron (PF-06882961), an oral small-molecule glucagon-like peptide-1 receptor agonist, in Japanese adults with type 2 diabetes mellitusRyosuke Ono, Kenichi Furihata, Yoshihiko Ichikawa, et al.
Diabetes, Obesity & Metabolism|November 26, 2022
Effects of intensive blood pressure lowering in patients with diabetes: A pooled analysis of the STEP and ACCORD-BP randomized trialsRuixue Yang, Jingjing Bai, Zhou Fang, et al.
Diabetes, Obesity & Metabolism|June 17, 2022
Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo-controlled crossover studyShoshana S Tell, Michal Schafer, Timothy Vigers, et al.
Diabetes, Obesity & Metabolism|October 8, 2021
Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trialsYuichiro Yamada, Daisuke Yabe, Christin Løth Hertz, et al.
Diabetes, Obesity & Metabolism|October 8, 2021
Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME)Jeff Unger, Dale C Allison, Margit Kaltoft, et al.
Pageof 627